DOI QR코드

DOI QR Code

Metabolic Activities of Ginseng and Its Constituents, Ginsenoside Rb1 and Rg1, by Human Intestinal Microflora

  • Choi, Jong-Ryul (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University) ;
  • Hong, Sung-Woon (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University) ;
  • Kim, Yu-Ri (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University) ;
  • Jang, Se-Eun (Department of Food and Nutrition, Kyung Hee University) ;
  • Kim, Nam-Jae (East-West Medical Research Institute, Kyung Hee University) ;
  • Han, Myung-Joo (Department of Food and Nutrition, Kyung Hee University) ;
  • Kim, Dong-Hyun (Department of Life and Nanopharmaceutical Sciences, Kyung Hee University)
  • Received : 2011.01.28
  • Accepted : 2011.03.17
  • Published : 2011.09.25

Abstract

To evaluate the difference in expressing pharmacological effects of ginseng by intestinal microflora between Koreans, metabolic activities of ginseng, ginsenoside $Rb_1$ and $Rg_1$ by 100 fecal specimens were measured. The ${\beta}$-glucosidase activity for p-nitrophenyl-${\beta}$-D-glucopyranoside was 0 to 0.42 mmol/min/mg and its average activity (mean${\pm}$SD) was $0.10{\pm}0.07$ mmol/min/mg. The metabolic activities of ginsenosides Rb1 and Rg1 were 0.01 to 0.42 and 0.01 to 0.38 pmol/min/mg, respectively. Their average activities were $0.25{\pm}0.08$ and $0.15{\pm}0.09$ pmol/min/mg, respectively. The compound K-forming activities from ginsenoside Rb1 and ginseng extract were 0 to 0.11 and 0 to 0.02 pmol/min/mg, respectively. Their average compound K-forming activities were $0.24{\pm}0.09$ pmol/min/ mg and $2.14{\pm}3.66$ fmol/min/mg, respectively. These activities all were not different between males and females, or between ages. Although compound K-forming activity from the aqueous extract of ginseng was low compared to that from ginenoside $Rb_1$, their profiles were similar to those of isolated compounds. Based on these findings, we believe that the intestinal bacterial metabolic activities of ginseng components are variable in individuals and may be used as selection markers for responders to ginseng.

Keywords

References

  1. Kobashi K, Akao T. Relation of intestinal bacteria to pharmacological effect of glycosides. Biosci Microflora 1997; 16:1-7. https://doi.org/10.12938/bifidus1996.16.1
  2. Kim DH. Intestinal microflora activate the pharmacological effects of herbal medicines. Nat Prod Sci 2002;8:35- 43.
  3. Akao T, Kida H, Kanaoka M, Hattori M, Kobashi K. Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng. J Pharm Pharmacol 1998;50:1155-1160. https://doi.org/10.1111/j.2042-7158.1998.tb03327.x
  4. Akao T, Kanaoka M, Kobashi K. Appearance of compound K, a major metabolite of ginsenoside Rb1 by intestinal bacteria, in rat plasma after oral administration- -measurement of compound K by enzyme immunoassay. Biol Pharm Bull 1998;21:245-249. https://doi.org/10.1248/bpb.21.245
  5. Lee J, Lee E, Kim D, Lee J, Yoo J, Koh B. Studies on absorption, distribution and metabolism of ginseng in humans after oral administration. J Ethnopharmacol 2009;122:143-148. https://doi.org/10.1016/j.jep.2008.12.012
  6. Wakabayashi C, Murakami K, Hasegawa H, Murata J, Saiki I. An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells. Biochem Biophys Res Commun 1998;246:725-730. https://doi.org/10.1006/bbrc.1998.8690
  7. Choo MK, Park EK, Han MJ, Kim DH. Antiallergic activity of ginseng and its ginsenosides. Planta Med 2003;69:518-522. https://doi.org/10.1055/s-2003-40653
  8. Bae EA, Choo MK, Park EK, Park SY, Shin HY, Kim DH. Metabolism of ginsenoside R(c) by human intestinal bacteria and its related antiallergic activity. Biol Pharm Bull 2002;25:743-747. https://doi.org/10.1248/bpb.25.743
  9. Bae EA, Kim NY, Han MJ, Choo MK, Kim DH. Transformation of ginsenosides to compound K (IH-901) by lactic acid bacteria of human intestine. J Microbiol Biotechnol 2003;13:9-14.
  10. Kobashi K, Nakata H, Takebe H, Terasawa K. Relation of intestinal microflora to Syo. Wakan-iyaku-kaishi 1984;1:166-167.
  11. Bae EA, Han MJ, Kim EJ, Kim DH. Transformation of ginseng saponins to ginsenoside Rh2 by acids and human intestinal bacteria and biological activities of their transformants. Arch Pharm Res 2004;27:61-67. https://doi.org/10.1007/BF02980048
  12. Kim YS, Kim JJ, Cho KH, Jung WS, Moon SK, Park EK, Kim DH. Biotransformation of ginsenoside $Rb_{1}$, crocin, amygdalin, geniposide, puerarin, ginsenoside Re, hesperidin, poncirin, glycyrrhizin, and baicalin by human fecal microflora and its relation to cytotoxicity against tumor cells. J Microbiol Biotechnol 2008;18:1109-1114.
  13. Lee DS, Kim YS, Ko CN, Cho KH, Bae HS, Lee KS, Kim JJ, Park EK, Kim DH. Fecal metabolic activities of herbal components to bioactive compounds. Arch Pharm Res 2002;25:165-169. https://doi.org/10.1007/BF02976558
  14. Yim JS, Kim YS, Moon SK, Cho KH, Bae HS, Kim JJ, Park EK, Kim DH. Metabolic activities of ginsenoside Rb1, baicalin, glycyrrhizin and geniposide to their bioactive compounds by human intestinal microflora. Biol Pharm Bull 2004;27:1580-1583. https://doi.org/10.1248/bpb.27.1580
  15. Mallet AK, Rowland IR, Bearne CA, Flynn JC, Fehilly BT, Udeen YS, Farthing MJ. Effect of dietary supplements of apple pectin, wheat bran or fat on the enzyme activity of the human faecal flora. Microb Ecol Health Dis 1988;1:23-39. https://doi.org/10.3109/08910608809140175
  16. Reddy BS, Hanson D, Mangat S, Mathews L, Sbaschnig M, Sharma C, Simi B. Effect of high-fat, high-beef diet and of mode of cooking of beef in the diet on fecal bacterial enzymes and fecal bile acids and neutral sterols. J Nutr 1980;110:1880-1887. https://doi.org/10.1093/jn/110.9.1880
  17. Mykkanen H, Laiho K, Salminen S. Variations in faecal bacterial enzyme activities and associations with bowel function and diet in elderly subjects. J Appl Microbiol 1998;85:37-41. https://doi.org/10.1046/j.1365-2672.1998.00454.x
  18. Ikeda N, Saito Y, Shimizu J, Ochi A, Mizutani J, Watabe J. Variations in concentrations of bacterial metabolites, enzyme activities, moisture, pH and bacterial composition between and within individuals in faeces of seven healthy adults. J Appl Bacteriol 1994;77:185-194. https://doi.org/10.1111/j.1365-2672.1994.tb03063.x
  19. Bae EA, Park SY, Kim DH. Constitutive beta-glucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria. Biol Pharm Bull 2000;23:1481-1485. https://doi.org/10.1248/bpb.23.1481
  20. Rumney CJ, Rowland IR. In vivo and in vitro models of the human colonic flora. Crit Rev Food Sci Nutr 1992;31:299-331. https://doi.org/10.1080/10408399209527575
  21. Simon GL, Gorbach SL. The human intestinal microflora. Dig Dis Sci 1986;31(9 Suppl):147S-162S. https://doi.org/10.1007/BF01295996
  22. Goldin BR, Swenson L, Dwyer J, Sexton M, Gorbach SL. Effect of diet and Lactobacillus acidophilus supplements on human fecal bacterial enzymes. J Natl Cancer Inst 1980;64:255-261. https://doi.org/10.1093/jnci/64.2.255
  23. Ling WH, Korpela R, Mykkanen H, Salminen S, Hanninen O. Lactobacillus strain GG supplementation decreases colonic hydrolytic and reductive enzyme activities in healthy female adults. J Nutr 1994;124:18-23. https://doi.org/10.1093/jn/124.1.18
  24. Kim DH. The possible role of intestinal microflora in pharmacological activities of ginseng. Int J Biomed Pharm Sci 2011; in press.

Cited by

  1. The Role of Intestinal Microflora in Anti-Inflammatory Effect of Baicalin in Mice vol.20, pp.1, 2012, https://doi.org/10.4062/biomolther.2012.20.1.036
  2. Bioconversion of ginsenoside Rc into Rd by a novel α-l-arabinofuranosidase, Abf22-3 from Leuconostoc sp. 22-3: cloning, expression, and enzyme characterization vol.103, pp.4, 2013, https://doi.org/10.1007/s10482-012-9856-2
  3. Lactobacillus ginsenosidimutans sp. nov., isolated from kimchi with the ability to transform ginsenosides vol.103, pp.4, 2013, https://doi.org/10.1007/s10482-012-9868-y
  4. Recent biotechnological progress in enzymatic synthesis of glycosides vol.40, pp.12, 2013, https://doi.org/10.1007/s10295-013-1332-0
  5. Comparative Analysis of the Gut Microbiota in People with Different Levels of Ginsenoside Rb1 Degradation to Compound K vol.8, pp.4, 2013, https://doi.org/10.1371/journal.pone.0062409
  6. Characterization of the ginsenoside-transforming recombinant β-glucosidase from Actinosynnema mirum and bioconversion of major ginsenosides into minor ginsenosides vol.97, pp.2, 2013, https://doi.org/10.1007/s00253-012-4324-5
  7. Protopanaxadiol, an Active Ginseng Metabolite, Significantly Enhances the Effects of Fluorouracil on Colon Cancer vol.7, pp.2, 2015, https://doi.org/10.3390/nu7020799
  8. Ginsenoside Rb1 protects the intestinal mucosal barrier following peritoneal air exposure vol.12, pp.4, 2016, https://doi.org/10.3892/etm.2016.3639
  9. Biotransformation and metabolic profile of anemoside B4 with rat small and large intestine microflora by ultra-performance liquid chromatography-quadrupole time-of-flight tandem mass spectrometry vol.31, pp.5, 2016, https://doi.org/10.1002/bmc.3873
  10. Mucilaginibacter pocheonensis sp. nov., with ginsenoside-converting activity, isolated from soil of a ginseng-cultivating field vol.66, pp.8, 2016, https://doi.org/10.1099/ijsem.0.001069
  11. Comparative Analysis of the Rats’ Gut Microbiota Composition in Animals with Different Ginsenosides Metabolizing Activity vol.65, pp.2, 2017, https://doi.org/10.1021/acs.jafc.6b04848
  12. Evaluation of structure–activity relationships of ginsenosides against amyloid β induced pathological behaviours in transgenic Caenorhabditis elegans vol.7, pp.64, 2017, https://doi.org/10.1039/C7RA05717B
  13. Effect of Fermented Red Ginseng Extract Enriched in Ginsenoside Rg3 on the Differentiation and Mineralization of Preosteoblastic MC3T3-E1 Cells vol.18, pp.5, 2015, https://doi.org/10.1089/jmf.2014.3251
  14. Reductive soil disinfestation effectively alleviates the replant failure of Sanqi ginseng through allelochemical degradation and pathogen suppression pp.1432-0614, 2019, https://doi.org/10.1007/s00253-019-09676-4
  15. Development of Fecal Microbial Enzyme Mix for Mutagenicity Assay of Natural Products vol.22, pp.6, 2011, https://doi.org/10.4014/jmb.1112.12028
  16. Enzymatic Transformation of Ginsenoside Rb1 by Lactobacillus pentosus Strain 6105 from Kimchi vol.36, pp.3, 2011, https://doi.org/10.5142/jgr.2012.36.3.291
  17. Development and validation of an LC-MS/MS method for determination of compound K in human plasma and clinical application vol.37, pp.1, 2013, https://doi.org/10.5142/jgr.2013.37.135
  18. Heat-processed ginseng saponin ameliorates the adenine-induced renal failure in rats vol.37, pp.1, 2011, https://doi.org/10.5142/jgr.2013.37.87
  19. Mucilaginibacter ginsenosidivorax sp. nov., with ginsenoside converting activity isolated from sediment vol.51, pp.3, 2013, https://doi.org/10.1007/s12275-013-2653-4
  20. Gut Microbiota-Mediated Drug Interactions between Lovastatin and Antibiotics vol.42, pp.9, 2014, https://doi.org/10.1124/dmd.114.058354
  21. A prebiotic fiber increases the formation and subsequent absorption of compound K following oral administration of ginseng in rats vol.39, pp.2, 2011, https://doi.org/10.1016/j.jgr.2014.11.002
  22. Comparative analysis of the expression level of recombinant ginsenoside-transforming β -glucosidase in GRAS hosts and mass production of the ginsenoside Rh 2 -Mix vol.12, pp.4, 2011, https://doi.org/10.1371/journal.pone.0176098
  23. Identification of novel glycoside hydrolases via whole genome sequencing of Niabella ginsenosidivorans for production of various minor ginsenosides vol.9, pp.7, 2011, https://doi.org/10.1007/s13205-019-1776-7
  24. Ophiopogon Polysaccharide Promotes the In Vitro Metabolism of Ophiopogonins by Human Gut Microbiota vol.24, pp.16, 2011, https://doi.org/10.3390/molecules24162886
  25. Enzymatic hydrolysis increases ginsenoside content in Korean red ginseng (Panax ginseng CA Meyer) and its biotransformation under hydrostatic pressure vol.99, pp.15, 2011, https://doi.org/10.1002/jsfa.9965
  26. Autotoxic Ginsenoside Disrupts Soil Fungal Microbiomes by Stimulating Potentially Pathogenic Microbes vol.86, pp.9, 2011, https://doi.org/10.1128/aem.00130-20
  27. Glucuronides Hydrolysis by Intestinal Microbial β-Glucuronidases (GUS) Is Affected by Sampling, Enzyme Preparation, Buffer pH, and Species vol.13, pp.7, 2021, https://doi.org/10.3390/pharmaceutics13071043
  28. Biotransformation of Ginsenosides (Rb1, Rb2, Rb3, Rc) in Human Intestinal Bacteria and Its Effect on Intestinal Flora vol.18, pp.12, 2011, https://doi.org/10.1002/cbdv.202100296